Cargando…
A COVID-19 prophylaxis? Lower incidence associated with prophylactic administration of ivermectin
As COVID-19 (coronavirus disease 2019) continues to rapidly spread throughout the world, the incidence varies greatly among different countries. These differences raise the question whether nations with a lower incidence share any medical commonalities that could be used not only to explain that low...
Autores principales: | Hellwig, Martin D., Maia, Anabela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd and International Society of Antimicrobial Chemotherapy.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698683/ https://www.ncbi.nlm.nih.gov/pubmed/33259913 http://dx.doi.org/10.1016/j.ijantimicag.2020.106248 |
Ejemplares similares
-
Repurposing Potential of the Antiparasitic Agent Ivermectin for the Treatment and/or Prophylaxis of COVID-19
por: Awad, Hoda, et al.
Publicado: (2022) -
Ivermectin for Prophylaxis and Treatment of COVID-19: A Systematic Review and Meta-Analysis
por: Cruciani, Mario, et al.
Publicado: (2021) -
Is ivermectin ready to be part of a public health policy for COVID-19 prophylaxis?
por: Ramírez, Céleo, et al.
Publicado: (2021) -
Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19
por: Kory, Pierre, et al.
Publicado: (2021) -
Effect of Ivermectin prophylaxis in prevention of COVID 19: Meta-analysis and systematic review
por: Kujur, Manisha, et al.
Publicado: (2022)